menu
    • menu

    Company profile for Connect Biopharma

    NEW Drugs in Dev: 3
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Connect Biopharmaceuticals is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. We have leveraged our expertise in the biology of T cell modulation to build a strong portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. We believe that by creati...
    Connect Biopharmaceuticals is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. We have leveraged our expertise in the biology of T cell modulation to build a strong portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. We believe that by creating drug molecules that are disease pathway specific, we can deliver novel medicines with better efficacy and fewer side effects.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Connect BiopharmaChina Flag
    Country
    Country
    China
    Address
    Address
    Science and Technology Park, East R&D Building , 3rd Floor, Beijing West Road,...
    Telephone
    Telephone
    0512-53577866
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.connectbiopharm.com/index.html
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Connect Biopharma Advances Seabreeze STAT Phase 2 Post-Interim
    Connect Biopharma Advances Seabreeze STAT Phase 2 Post-Interim

    23 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/23/3280016/0/en/connect-biopharma-announces-enrollment-in-phase-2-seabreeze-stat-studies-will-continue-as-planned-following-pre-specified-interim-analysis.html

    GLOBENEWSWIRE
    23 Apr 2026
    Share Share
    Connect Bio Reports 2025 Financials And Business Update
    Connect Bio Reports 2025 Financials And Business Update

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3266034/0/en/Connect-Biopharma-Reports-2025-Full-Year-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share
    Rademikibart Show Best-in-Class Potential in Ph3 AD Dermatitis
    Rademikibart Show Best-in-Class Potential in Ph3 AD Dermatitis

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3264498/0/en/Rademikibart-Demonstrates-Best-in-Class-Potential-in-Phase-3-Atopic-Dermatitis-Study.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share
    Connect Bio: Phase 1 (IV) Rademikibart Data In Asthma, COPD
    Connect Bio: Phase 1 (IV) Rademikibart Data In Asthma, COPD

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3264480/0/en/Connect-Biopharma-Announces-Positive-Topline-Data-from-its-Phase-1-Study-of-Intravenous-IV-Rademikibart-in-Patients-with-Asthma-or-COPD.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Connect Bio Secures $20.2M In Private Placement Financing
    Connect Bio Secures $20.2M In Private Placement Financing

    30 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/30/3264500/0/en/Connect-Biopharma-Announces-20-2-Million-Private-Placement-Financing.html

    GLOBENEWSWIRE
    30 Mar 2026
    Share Share
    Connect Bio To Present At Leerink Partners Global Healthcare Conf
    Connect Bio To Present At Leerink Partners Global Healthcare Conf

    03 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/03/3248424/0/en/Connect-Biopharma-to-Present-at-the-Leerink-Partners-Global-Healthcare-Conference.html

    GLOBENEWSWIRE
    03 Mar 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search